A new technology makes possible simultaneous analysis of diagnostic specimens from thousands of individuals revealing the presence of SARS-CoV-2 coronaviruses. . . . → Read More: Process Tests Thousands of Covid-19 Samples at Once
|
|||||
|
       
  |
The U.S. Food and Drug Administration yesterday issued guidance for Covid-19 vaccine developers, requiring extended follow-up with clinical trial participants. . . . → Read More: FDA Bucks White House, Issues Strict Vaccine Guidance  Comments are closed  Regulations  biomedical, clinical trials, Covid-19, FDA, health care, life sciences, pharmaceuticals 
A biomedical engineering lab and analytics company are testing the feasibility of algorithms to find early signs of Covid-19 symptoms from smart watch users. . . . → Read More: Study Testing Wearables Data for Covid-19 Clues 3 comments - (Comments are closed) Joint ventures/collaborations, New products biomedical, computer science, Covid-19, engineering, entrepreneurs, FDA, life sciences, mathematics, medical device, physical sciences, software, university 
In a joint statement today, CEOs of nine companies promised to follow the highest ethical and scientific standards in development and testing of their Covid-19 vaccines. . . . → Read More: Biotechs, Pharmas Vow Not to Rush Covid-19 Vaccines One comment - (Comments are closed) Regulations biomedical, biotechnology, clinical trials, Covid-19, Europe, FDA, health care, life sciences, NIH, pharmaceuticals 
An expert panel convened by National Institutes of Health says current data do not support recommending convalescent plasma as a treatment for Covid-19 infections. . . . → Read More: NIH Nixes Convalescent Plasma Covid-19 Therapy Comments are closed Regulations biomedical, clinical trials, Covid-19, FDA, health care, life sciences, NIH, pharmaceuticals, university 
Global drug maker AstraZeneca is starting its late-stage Covid-19 vaccine clinical trial in the U.S., with a vow not to cut corners in its processes. . . . → Read More: Late-Stage Covid-19 Vaccine Trial Underway in U.S. 2 comments - (Comments are closed) New products, Regulations biomedical, biotechnology, clinical trials, Covid-19, FDA, genomics, life sciences, pharmaceuticals, U.K., university 
Aimmune Therapeutics Inc., a developer of food allergy drugs, was acquired today by global consumer products company Nestlé for $2.6 billion. . . . → Read More: Food Allergy Biotech Acquired for $2.6B One comment - (Comments are closed) Finance biomedical, biotechnology, equity, Europe, FDA, investment, life sciences, merger, pharmaceuticals 
National Institutes of Health awarded contracts to seven companies for higher-speed Covid-19 detection tests to ease current reporting delays. . . . → Read More: NIH Issues Contracts for Faster Covid-19 Diagnostics One comment - (Comments are closed) Finance, New products biomedical, biotechnology, contract, Covid-19, FDA, health care, life sciences, medical device, NIH
National Institutes of Health is expanding its challenge competition to make tests for Covid-19 viruses more widely available and return results faster. . . . → Read More: NIH Expands Covid-19 Test Technology Challenge 2 comments - (Comments are closed) Finance, New products biomedical, challenge, Covid-19, engineering, FDA, life sciences, medical device, NIH 
An experimental vaccine to prevent Covid-19 infections, given as a nasal spray, produces immune responses in tests with lab mice. . . . → Read More: Immune Responses Shown in Covid-19 Nasal Vaccine One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, Covid-19, FDA, life sciences, pharmaceuticals, preclinical, university |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||